Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition

被引:32
作者
Schroijen, Marielle A. [1 ,2 ]
Dekkers, Olaf M. [1 ,2 ]
Grootendorst, Diana C. [1 ]
Noordzij, Marlies [3 ]
Romijn, Johannes A. [2 ]
Krediet, Raymond T. [4 ]
Boeschoten, Elisabeth W. [5 ]
Dekker, Friedo W. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2333 ZA Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2333 ZA Leiden, Netherlands
[3] Acad Med Ctr Amsterdam, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands
[4] Acad Med Ctr Amsterdam, Dept Nephrol, NL-1105 AZ Amsterdam, Netherlands
[5] Hans Mak Inst, NL-1411 EL Naarden, Netherlands
关键词
GLYCATION END-PRODUCTS; REPLACEMENT THERAPY; PERITONEAL-DIALYSIS; MELLITUS; HEMODIALYSIS; REGISTRIES; PROTEIN; EUROPE; IMPACT; RISK;
D O I
10.1186/1471-2369-12-69
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: On dialysis, survival among patients with diabetes mellitus is inferior to survival of non-diabetic patients. We hypothesized that patients with diabetes as primary renal disease have worse survival compared to patients with diabetes as a co-morbid condition and aimed to compare all-cause mortality between these patient groups. Methods: Data were collected from the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD), a multicenter, prospective cohort study in which new patients with end stage renal disease (ESRD) were monitored until transplantation or death. Patients with diabetes as primary cause of ESRD were compared with patients with diabetes as co-morbid condition and both of these patient groups were compared to patients without diabetes. Analysis was performed using Kaplan-Meier and Cox regression. Results: Fifteen % of the patients had diabetic nephropathy as primary renal disease (N = 281); 6% had diabetes as co-morbid condition (N = 107) and 79% had no diabetes (N = 1465). During follow-up 42% of patients (N = 787) died. Compared to non-diabetic patients, mortality risk was increased for both patients with diabetes as primary renal disease HR: 1.9 (95% CI 1.6, 2.3) and for patients with diabetes as co-morbid condition HR: 1.7 (95% CI 1.3, 2.2). Mortality was not significantly higher in patients with diabetes as primary renal disease compared to patients with diabetes as co-morbid condition (HR 1.06; 95% CI 0.79, 1.43). Conclusions: This study in patients with ESRD showed no survival difference between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. Both conditions were associated with increased mortality risk compared to non-diabetic patients.
引用
收藏
页数:7
相关论文
共 25 条
[1]   Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells [J].
Berrou, J. ;
Tostivint, I. ;
Verrecchia, F. ;
Berthier, C. ;
Boulanger, E. ;
Mauviel, A. ;
Marti, H. P. ;
Wautier, M. P. ;
Wautier, J. L. ;
Rondeau, E. ;
Hertig, A. .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 23 (04) :513-520
[2]   Risk of end-stage renal disease in diabetes mellitus - A prospective cohort study of men screened for MRFIT [J].
Brancati, FL ;
Whelton, PK ;
Randall, BL ;
Neaton, JD ;
Stamler, J ;
Klag, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (23) :2069-2074
[3]   RENAL REPLACEMENT THERAPY IN PATIENTS WITH DIABETIC NEPHROPATHY, 1980-1985 [J].
BRUNNER, FP ;
BRYNGER, H ;
CHALLAH, S ;
FASSBINDER, W ;
GEERLINGS, W ;
SELWOOD, NH ;
TUFVESON, G ;
WING, AJ .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1988, 3 (05) :585-595
[4]  
Catalano C, 1996, NEPHROL DIAL TRANSPL, V11, P1124
[5]  
Cooper L, 2001, Nephrol News Issues, V15, P38
[6]  
Cooper L, 2001, Nephrol News Issues, V15, P43
[7]  
Cooper L, 2001, Nephrol News Issues, V15, P34
[8]  
ERA-EDTA Registry, 2009, ERA EDTA REG 2006 AN
[9]   INFLUENCE OF DIALYSIS MODALITY ON PLASMA AND TISSUE CONCENTRATIONS OF PENTOSIDINE IN PATIENTS WITH END-STAGE RENAL-DISEASE [J].
FRIEDLANDER, MA ;
WU, YC ;
SCHULAK, JA ;
MONNIER, VM ;
HRICIK, DE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) :445-451
[10]  
Holmes CJ, 2000, PERITON DIALYSIS INT, V20, pS37